St John's College, Cambridge
6-7 September 2010

9.00-9.30

Coffee and Registration
 

9.30-11.00

Sir Greg Winter CBE FRS - MRC Laboratory of Molecular Biology, UK
Richard Lerner - President, The Scripps Research Institute, USA
John McCafferty - University of Cambridge, UK
 

11.00-11.30

Coffee
 

11.30-12.30

Carl Borrebaeck - Lund University, Sweden
Jim Huston - Chairman, The Antibody Society, USA
Richard Begent - University College London, UK
 

12.30-2.00

Lunch
 

2.00-3.30

Andreas Plückthun - University of Zurich, Switzerland
Bob Ladner - Dyax Corp, USA
Jane Osbourn - MedImmune Ltd., UK
 

3.00-3.30

Coffee
 

3.30-3.50

How IP shaped the Phage Display world 
Diane Wilcock - XOMA LLC, USA
 

3.50-5.00

Panel Discussion
Twenty Years of Phage Display: the Highs and Lows 

Chair:

Panellists

Debbie Allen - Andiamo Biotech, UK
Andrew Bradbury - Los Alamos National Laboratories, USA
David Chiswell - Nabriva Therapeutics, Austria
Hennie Hoogenboom  - The Netherlands
Diane Mellett - Affitech A/S, Norway
Thomas von Rueden - DIREVO Industrial Biotechnology GmbH, Germany
 

6.30 -7.30       

Pre-dinner drinks
 

8.00-11.00      

Conference dinner
Special Guest Lecture: The HUMIRA Story   
Bob Kamen - Former President, Abbott Bioresearch Center, USA 

9.00-9.30

Coffee and Welcome
 

9.30-11.00

Markus Enzelberger - MorphoSys AG, Germany
Dario Neri - ETH Zurich, Switzerland
Ian Tomlinson - GlaxoSmithKline, UK
 

11.00-11.30

Coffee
 

11.30-12.30

Dev Sidhu - University of Toronto, Canada
Stefan Dübel - Technical University of Braunschweig, Germany
Tristan Vaughan - Medimmune Ltd., UK
 

12.30-2.00

Lunch
 

2.00-3.30

Kevin Johnson - PanGenetics BV, UK
Jim Marks - University of California, San Francisco, USA
Trudi Veldman - Abbott Bioresearch Center, USA
 

3.30-4.15

Discussion Forum: Perspective on the Next 20 Years
(with refreshments)    
 

4.15 onwards

Drinks with closing discussion
Optional punting